Thoracic Oncology Laboratory »  Publications

Publications

View by Year:
 
Kratz JR, Tham PT, Mulvihill MS, Ziaei F, Ray MR, Hurst JW, Segal MR, Berryman DM, Chu W, He B, Jablons DM, Mann MJ
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B, Jun-2013;22(2):65-9.
Mulvihill MS, Kratz JR, Pham P, Jablons DM, He B
The role of stem cells in airway repair: implications for the origins of lung cancer.
Chinese journal of cancer, Feb-2013;32(2):71-4.  Epub 2012 Nov 1.
Zhang Y, He J, Zhang F, Li H, Yue D, Wang C, Jablons DM, He B, Lui N
SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.
Journal of experimental & clinical cancer research : CR, 2013;[epublish]32:7.
Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons DM, He B
Gli as a novel therapeutic target in malignant pleural mesothelioma.
PloS one, 2013;8(3):e57346.
Kim IJ, Quigley D, To MD, Pham P, Lin K, Jo B, Jen KY, Raz D, Kim J, Mao JH, Jablons D, Balmain A
Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas.
Nature communications, 2013;4:1701.
Mo ML, Chen Z, Zhou HM, Li H, Hirata T, Jablons DM, He B
Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer.
Journal of experimental & clinical cancer research : CR, 2013;[epublish]32:29.
Tsao MS, Jablons DM
Molecular prognostication of non-small cell lung cancer.
Seminars in thoracic and cardiovascular surgery, 2013;25(1):4-7.
Bravo DT, Yang YL, Kuchenbecker K, Hung MS, Xu Z, Jablons DM, You L
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer.
BMC cancer, 2013;[epublish]13:316.
Liu S, Hsieh D, Yang YL, Xu Z, Peto C, Jablons DM, You L
Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
BMC pharmacology & toxicology, 2013;[epublish]14:36.
Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, Li H, Zhou HM, Jablons DM, He B
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
PloS one, 2013;[epublish]8(8):e71816.
Kratz JR, Van den Eeden SK, He J, Jablons DM, Mann MJ
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
JAMA, Oct-24-2012;308(16):1629-31.
Kim JW, Lee S, Lui N, Choi H, Mulvihill M, Fang LT, Kang HC, Kwon YW, Jablons D, Kim IJ
A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
Oncology reports, Oct-2012;28(4):1225-30.  Epub 2012 Jul 26.
Li T, Hou SC, Mao JH, Wang YC, Lu XD, Tan JL, You B, Liu YP, Ni J, Au A, Jablons DM, Xu Z, You L
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma.
Journal of clinical pathology, Sep-2012;65(9):855-8.  Epub 2012 May 8.
Choi H, Kratz J, Pham P, Lee S, Ray R, Kwon YW, Mao JH, Kang HC, Jablons D, Kim IJ
Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
International journal of oncology, Jun-2012;40(6):1900-6.  Epub 2012 Mar 07.
Yom SS, Chen CP, Jahan TM, Jablons DM
One size does not fit all lung cancer patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, May-2012;7(5):945.
[    1  2  3  4  5  6  7  8  9  10  11     View All ]
X